A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.
Patient Reported Impact of Psoriasis and Desired Treatment Outcomes
Understanding the holistic impact is crucial to enabling patients to live more fulfilling lives. For this research presented at the 2025 Fall Clinical Dermatology Conference, 98 members of MyPsoriasisTeam living with psoriasis were interviewed to better understand patient-desired outcomes and help dermatologists develop more effective approaches to treatment. The emotional toll of psoriasis manifests in […]
Meet Swoop’s VP Medical Strategy and Commercial Consulting Dr. Duré Hussain. She brings a unique clinical perspective to digital healthcare marketing and agentic AI to improve patient outcomes.
I believe in the power of data-driven omnichannel strategies, but so many in our industry don’t understand what matters: Connecting with the right audiences on the right channels.
From gathering real-time data to inform marketing strategies to improving the overall patient experience, AI-powered virtual agents can help personalize customer interactions.
At MyHealthTeam’s all-company get-together in Nashville, we invited five pharma marketing experts from top agencies and biotechs to join me on a panel. We discussed the “New Marketing Playbook” for everything from rare disease launches to direct-to-patient models to innovative uses of AI with patients.
“The Reuters Pharma USA conference, held this spring in Philadelphia, is one of the best conferences attended by and featuring pharma executives. Here are our notes on some of the top themes and actionable takeaways from the event.”
“Data is not created equally. Understanding the difference between zero-party and first-party data can be game-changing for pharma marketers. Below is a guide on how pharma marketers can reach more of the right people with less waste.”